Randomised Trial Finds Obesity Medication Liraglutide Safe and Effective For Children Under 12 Dr. Garima Soni12 Sept 2024 8:30 AM ISTThe obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research presented at the annual meeting of the...
Liraglutide improves myocardial perfusion, myocardial energetics and exercise capacity in Diabetics without CVD: Study Dr. Shravani Dali5 Aug 2024 9:00 AM ISTLiraglutide improves myocardial perfusion, myocardial energetics and exercise capacity in Diabetics without CVD suggests a study published in the...
Submit CT data of Liraglutide pre-filled pen for type 2 DM: CDSCO Panel Tells Biocon Pharma Dr. Divya Colin3 Aug 2024 6:00 PM ISTNew Delhi: Citing that the approved indication for BIOLIDE synthetic Liraglutide 6mg/ml solution for injection in a pre-filled pen in UK-MHRA is for...
Liraglutide-Associated Depression in Type 2 Diabetes Patient: Case Report Raises Concerns Medha Baranwal7 Jun 2024 9:00 AM ISTChina: A recent case report has drawn attention to a potential association between liraglutide, a commonly prescribed medication for type 2 diabetes,...
Biocon, Medix join hands for commercialization of weight management drug Liraglutide in Mexico Ruchika Sharma13 May 2024 12:01 PM ISTBengaluru: Biocon Limited, an innovation-led global biopharmaceutical company, today announced the signing of a semi-exclusive distribution and...
Biocon gets MHRA UK nod for weight management injection Liraglutide Ruchika Sharma1 April 2024 2:22 PM ISTBangalore: Biocon Limited, through its European partner, Zentiva, has received approval from the Medicines and Healthcare Products Regulatory...
Biocon obtains approval for diabetes drug Liraglutide in UK Ruchika Sharma28 March 2024 2:30 PM ISTBengaluru: Biocon Limited, a global biopharmaceuticals company, has announced that the Company has received approval from the Medicines and...
Liraglutide can prevent PAD progression in patients with type 2 diabetes: STARDUST trial Medha Baranwal22 March 2024 7:45 PM ISTItaly: Compared with conventional treatment, liraglutide use over six months was associated with increased peripheral in patients with type 2 diabetes...
Liraglutide 3 mg per day Shows Efficacy in Weight Loss for Individuals with Bipolar Disorder: Study Dr Riya Dave11 March 2024 1:30 AM ISTObesity is prevalent among individuals with bipolar disorder (BD), posing significant health risks. Liraglutide, a medication indicated for chronic...
Liraglutide increases insulin sensitivity independent of weight loss in obese diabetics Dr. Kamal Kant Kohli16 Jan 2024 10:00 AM ISTUSA: A recent study published in Diabetes has shown weight loss-independent effect of liraglutide on insulin sensitivity in individuals with obesity...
Liraglutide does not impact heart rate or BP in diabetes patients during acute MI: Study Medha Baranwal11 Jan 2024 6:15 AM ISTChina: Liraglutide did not increase the heart rate of patients with diabetes during acute myocardial infarction (AMI) and did not lead to an increase...
Biocon collaborates with Juno Pharma for commercialization of diabetes treatment Liraglutide in Canada Ruchika Sharma7 Oct 2023 11:30 AM ISTBengaluru: Biocon Limited, an innovation-led global biopharmaceutical company, has announced the signing of a partnership agreement with Juno...
